Jump to content

Template:Sodium-glucose transporter modulators: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

26 January 2024

  • curprev 13:0113:01, 26 January 2024 A455bcd9 talk contribs 1,313 bytes 0 Only 10% of canagliflozin's effect comes from SGLT-1 inhibition and it is largely described in the literature as an SGLT2 inhibitor while sotagliflozin is described as the first dual SGLT1/2 inhibitor. Better to be consistent with RS here (although yes, canagliflozin also inhibits a bit SGLT1, but dapagliflozin also does it fwiw). undo Tag: 2017 wikitext editor

18 December 2023

17 December 2023

20 June 2018

19 June 2018